Scholarlink

Background <p>Globally tuberculosis disease (TB) poses a significant public health challenge. People deprived of liberty (PDL) are one of the most affected. This study aims to evaluate the positivity of interferon gamma release assay (IGRA) and molecular sputum testing for TB through a multicenter survey of Brazilian prisons and evaluate factors associated with IGRA positivity.</p> Methods <p>We performed a cross-sectional study among PDL in six male and two female prisons within 6 cities in Brazil in 2025. Eligible participants included consenting adults over 18 years. We randomized 130 individuals per site using prison census for evaluation with a sociodemographic questionnaire, blood testing with QuantiFERON-TB Gold Plus<sup>®</sup> (IGRA) and sputum testing with GeneXpert Ultra<sup>®</sup> (Xpert). We included individuals with complete data and valid IGRA results for analysis. Multivariable logistical regression was performed to evaluate factors associated with IGRA positivity stratified by gender.</p> Results <p>Among 1040 PDL randomized, 884 were included. The overall IGRA positivity was 53.6% (95% confidence interval [CI] 50.3–56.9) varying between 29.2% (21.6–38.2) and 84.0% (75.3–90.1) among prisons sites, male and female individuals had a positivity of 61.9% (58.1–65.5) and 30.3% (24.7–36.5), respectively. In the multivariable analysis, IGRA positivity was associated with lower education (adjusted odds ratio [aOR] 1.46, 95% CI 1.03–2.07, <i>p</i> = 0.034), previous incarceration (aOR 2.81, 1.85–4.25, <i>p</i> &lt; 0.001), previous TB history (aOR 2.99, 1.39–6.42, <i>p</i> &lt; 0.001) and incarceration time (&lt; 1 year as reference, 3–4 years: aOR 2.15, 1.18–3.92, <i>p</i> = 0.012; 5 years or above: aOR 2.85, 1.66–4.90, <i>p</i> &lt; 0.001) for males. In females, IGRA positivity was associated with previous TB history (aOR 5.93, 1.97–20.2, <i>p</i> = 0.002). One prison could not collect sputum samples; at the remaining sites we detected 20 individuals (2.5%, 20/770) with positive Xpert.</p> Conclusion <p>Despite variations among prisons and gender, IGRA and Xpert positivity were elevated across sites evaluated in Brazil. These findings underscore the urgent need for systematic and comprehensive tuberculosis screening, prevention, and control strategies in prisons, including the potential evaluation of new preventative technologies such as new TB vaccines.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Interferon gamma release assay and sputum GeneXpert positivity for tuberculosis burden detection in people deprived of liberty in Brazil: a cross-sectional study

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年5月12日

查看全文
  • Ghislaine Gonçalez de Araujo Arcanjo,
  • José Victor Bortolotto Bampi,
  • Karina Marques Santos,
  • Michele Souza Ventura,
  • Everton Ferreira Lemos,
  • Eduarda Gassen Boeira,
  • Lia Gonçalves Possuelo,
  • Giselle Lima de Freitas,
  • Beatriz do Carmo Veloso de Oliveira,
  • Jaquelane Silva Jesus,
  • Allyson Guimarães Costa,
  • Marcelo Cordeiro-Santos,
  • Mariana Pinheiro Alves Vasconcelos,
  • Mayara Gonçalves Tavares,
  • Rosilene Ruffato,
  • Beatriz Barreto-Duarte,
  • Pedro P. Carneiro,
  • Bruno B. Andrade,
  • Rebecca A. Clark,
  • Katherine A. Thomas,
  • Richard G. White,
  • Julio Croda

摘要

Background

Globally tuberculosis disease (TB) poses a significant public health challenge. People deprived of liberty (PDL) are one of the most affected. This study aims to evaluate the positivity of interferon gamma release assay (IGRA) and molecular sputum testing for TB through a multicenter survey of Brazilian prisons and evaluate factors associated with IGRA positivity.

Methods

We performed a cross-sectional study among PDL in six male and two female prisons within 6 cities in Brazil in 2025. Eligible participants included consenting adults over 18 years. We randomized 130 individuals per site using prison census for evaluation with a sociodemographic questionnaire, blood testing with QuantiFERON-TB Gold Plus® (IGRA) and sputum testing with GeneXpert Ultra® (Xpert). We included individuals with complete data and valid IGRA results for analysis. Multivariable logistical regression was performed to evaluate factors associated with IGRA positivity stratified by gender.

Results

Among 1040 PDL randomized, 884 were included. The overall IGRA positivity was 53.6% (95% confidence interval [CI] 50.3–56.9) varying between 29.2% (21.6–38.2) and 84.0% (75.3–90.1) among prisons sites, male and female individuals had a positivity of 61.9% (58.1–65.5) and 30.3% (24.7–36.5), respectively. In the multivariable analysis, IGRA positivity was associated with lower education (adjusted odds ratio [aOR] 1.46, 95% CI 1.03–2.07, p = 0.034), previous incarceration (aOR 2.81, 1.85–4.25, p < 0.001), previous TB history (aOR 2.99, 1.39–6.42, p < 0.001) and incarceration time (< 1 year as reference, 3–4 years: aOR 2.15, 1.18–3.92, p = 0.012; 5 years or above: aOR 2.85, 1.66–4.90, p < 0.001) for males. In females, IGRA positivity was associated with previous TB history (aOR 5.93, 1.97–20.2, p = 0.002). One prison could not collect sputum samples; at the remaining sites we detected 20 individuals (2.5%, 20/770) with positive Xpert.

Conclusion

Despite variations among prisons and gender, IGRA and Xpert positivity were elevated across sites evaluated in Brazil. These findings underscore the urgent need for systematic and comprehensive tuberculosis screening, prevention, and control strategies in prisons, including the potential evaluation of new preventative technologies such as new TB vaccines.